Semaglutide 7mg tablets, box of 30 tablets (Rybelsus/Novo Nordisk)

Semaglutide (Rybelsus) is approved for the treatment for type 2 diabetes. In diabetic patients, treatment with semaglutide (Rybelsus) has been shown to improve blood glucose levels. In addition, patients experience weight loss of 5-15% of body weight. Semaglutide (Rybelsus) is administered orally (once a day tablet), as compared to Semaglutide (Ozempic) or Semaglutide (WeGovy) which are subcutaneous injections.

(This is a prescription medication which should be used under the supervision of a medical professional)